ACI 2nd Annual GLP-1 Law & Policy Summit
With the market for GLP-1 medications projected to exceed $30 billion by 2030, the summit brought together industry leaders to discuss the opportunities and challenges shaping this fast-growing sector.
The information provided is not intended to be a comprehensive review of all developments in the law and practice, or to cover all aspects of those referred to.
Readers should take legal advice before applying it to specific issues or transactions.
Editorial Disclaimer
Originally published before the Ashurst Perkins Coie combination. See disclaimer.